EMA Authorised: Tecovirimat SIGA (tecovirimat) — SIGA Technologies Netherlands B.V.

View source ↗

Summary

The EMA authorized tecovirimat (SIGA) for multiple poxvirus infections, including monkeypox and smallpox, under the marketing authorization held by SIGA Technol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cowpox
• Monkeypox
• Poxviridae Infections
• Smallpox
• Vaccinia Infections

Drugs mentioned

• Tecovirimat (tecovirimat)

Snippet

Status: Authorised. Therapeutic area: Poxviridae Infections;Cowpox;Monkeypox;Vaccinia;Smallpox. MAH: SIGA Technologies Netherlands B.V.. Decision date: 28/05/2026